Xiaoxi Wang

2.5k total citations · 1 hit paper
82 papers, 1.6k citations indexed

About

Xiaoxi Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Xiaoxi Wang has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Epidemiology. Recurrent topics in Xiaoxi Wang's work include Nanoplatforms for cancer theranostics (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (6 papers). Xiaoxi Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immunotherapy and Immune Responses (6 papers). Xiaoxi Wang collaborates with scholars based in China, United States and Canada. Xiaoxi Wang's co-authors include Lie Wang, Liang Lin, Xiaodan Liang, Xiaopeng Yan, Ziliang Chen, Li Liu, Meng Shi, Hui Wu, Xueqin Zhu and Yanfeng Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Xiaoxi Wang

71 papers receiving 1.5k citations

Hit Papers

Meta R-CNN: Towards General Solver for Instance-Level Low... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxi Wang China 21 286 213 202 197 197 82 1.6k
Andrea Bauer Germany 35 112 0.4× 162 0.8× 99 0.5× 75 0.4× 330 1.7× 188 4.0k
Van-Huy Pham Vietnam 21 80 0.3× 154 0.7× 269 1.3× 85 0.4× 116 0.6× 72 1.4k
D. Scott Lind United States 27 113 0.4× 108 0.5× 349 1.7× 34 0.2× 408 2.1× 84 2.6k
Hui Chen China 27 76 0.3× 304 1.4× 189 0.9× 52 0.3× 171 0.9× 220 2.5k
Qing Liu China 23 115 0.4× 35 0.2× 299 1.5× 241 1.2× 639 3.2× 110 2.2k
Erping Long China 18 86 0.3× 142 0.7× 400 2.0× 88 0.4× 40 0.2× 63 2.1k
Guangquan Li China 16 65 0.2× 81 0.4× 370 1.8× 39 0.2× 93 0.5× 77 2.1k
Haoran Zhang China 16 67 0.2× 274 1.3× 83 0.4× 51 0.3× 115 0.6× 68 1.1k
Masafumi OKADA Japan 22 81 0.3× 64 0.3× 125 0.6× 30 0.2× 71 0.4× 145 1.6k
Cheng Zheng United States 28 65 0.2× 115 0.5× 553 2.7× 223 1.1× 179 0.9× 148 2.8k

Countries citing papers authored by Xiaoxi Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoxi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxi Wang more than expected).

Fields of papers citing papers by Xiaoxi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxi Wang. The network helps show where Xiaoxi Wang may publish in the future.

Co-authorship network of co-authors of Xiaoxi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxi Wang. A scholar is included among the top collaborators of Xiaoxi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxi Wang. Xiaoxi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lv, Yao, Xiaoxi Wang, Jingan Lou, et al.. (2025). Ruminococcus torques ameliorates the inflammation bowel disease and gut barrier dysfunction by modulating gut microbiota and bile acid metabolism. Journal of Translational Medicine. 23(1). 1162–1162.
2.
Wu, Kunpeng, Qingqing Li, Xiaoxi Wang, et al.. (2025). Chemoimmunotherapy as induction treatment in concurrent chemoradiotherapy for patients with nasopharyngeal carcinoma stage IVa. Annals of Medicine. 57(1). 2453091–2453091.
3.
Wang, Xiaoxi, Xueqin Zhu, Tiantian Zhang, et al.. (2025). Enhancing antigen presentation in cancer stem cells via peptide-based nanoparticles for effective immunotherapy. Journal of Controlled Release. 385. 114001–114001. 1 indexed citations
4.
Wang, Xu, Dan Guo, Xiaoxi Wang, et al.. (2025). Clinical application of mesenchymal stem cells in immunosenescence: a qualitative review of their potential and challenges. Stem Cell Research & Therapy. 16(1). 265–265. 1 indexed citations
5.
Liu, Jingjing, et al.. (2024). Mechanism exploration of Osteoking in the treatment of lumbar disc herniation based on network pharmacology and molecular docking. Journal of Orthopaedic Surgery and Research. 19(1). 88–88. 1 indexed citations
6.
Liu, Kun, et al.. (2024). <em>In Vivo</em> Calcium Imaging of Dorsal Root Ganglia Neurons' Response to Somatic and Visceral Stimuli. Journal of Visualized Experiments. 2 indexed citations
7.
Liu, Wenjuan, Nan Shen, Limin Zhang, et al.. (2024). Research in the application of artificial intelligence to lung cancer diagnosis. Frontiers in Medicine. 11. 1343485–1343485. 3 indexed citations
8.
Zhu, Xueqin, Xiaoxi Wang, Bing Jiang, et al.. (2024). Peroxidase‐Like Nanozyme Activates the cGAS‐STING Pathway via ROS‐Induced mtDNA Release for Cancer Immunotherapy. Advanced Functional Materials. 34(39). 21 indexed citations
9.
Zheng, Jie, Mingshuang Wang, Liwei Pang, et al.. (2024). Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy. Journal of Controlled Release. 373. 568–582. 16 indexed citations
10.
Song, Jin‐Chao, et al.. (2024). Relationship between age and remimazolam dose required for inducing loss of consciousness in older surgical patients. Frontiers in Medicine. 11. 1331103–1331103. 3 indexed citations
11.
Wu, Wenjun, Gao Yang, Xiaoxi Wang, et al.. (2022). Distributed Handoff Problem in Heterogeneous Networks With End-to-End Network Slicing: Decentralized Markov Decision Process-Based Modeling and Solution. IEEE Transactions on Wireless Communications. 21(12). 11222–11236. 7 indexed citations
12.
Yao, Yongjie, Xiaoxi Wang, Jiaxin Sun, et al.. (2021). Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8+ T lymphocytes. International Immunopharmacology. 100. 108152–108152. 4 indexed citations
14.
Lv, Dan, Zepu Wang, Shuai Ji, Xiaoxi Wang, & Huiqing Hou. (2021). Plasma Levels of Homocysteine is Associated with Liver Fibrosis in Health Check-Up Population. International Journal of General Medicine. Volume 14. 5175–5181. 4 indexed citations
15.
Wang, Zheng, Xiaoxi Wang, Fei Cheng, et al.. (2021). Rapamycin Inhibits Glioma Cells Growth and Promotes Autophagy by miR-26a-5p/DAPK1 Axis. Cancer Management and Research. Volume 13. 2691–2700. 21 indexed citations
16.
Li, Wanqiong, Xueqin Zhu, Xiuman Zhou, et al.. (2021). An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy. Journal of Controlled Release. 334. 376–388. 73 indexed citations
17.
Liu, Wei, et al.. (2018). Influencing factors of fear of progression among postoperative elderly patients with prostatic cancer. Zhonghua xiandai huli zazhi. 24(29). 3543–3547.
19.
Wang, Juan, Xiaoxi Wang, Jiajin Liu, et al.. (2013). Combined application of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques. Journal of International Medical Research. 42(1). 213–223. 5 indexed citations
20.
Wang, Xiaoxi. (2011). The level of serum matrix metalloproteinase-3 and its significance in patients with ankylosing spondylitis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026